Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

ADHD drugs and serious cardiovascular events in children and young adults.

Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, Murray KT, Quinn VP, Stein CM, Callahan ST, Fireman BH, Fish FA, Kirshner HS, O'Duffy A, Connell FA, Ray WA.

N Engl J Med. 2011 Nov 17;365(20):1896-904. doi: 10.1056/NEJMoa1110212. Epub 2011 Nov 1.

2.

ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.

Subcommittee on Attention-Deficit/Hyperactivity Disorder; Steering Committee on Quality Improvement and Management, Wolraich M, Brown L, Brown RT, DuPaul G, Earls M, Feldman HM, Ganiats TG, Kaplanek B, Meyer B, Perrin J, Pierce K, Reiff M, Stein MT, Visser S.

Pediatrics. 2011 Nov;128(5):1007-22. doi: 10.1542/peds.2011-2654. Epub 2011 Oct 16.

3.

Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children --- United States, 2003 and 2007.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2010 Nov 12;59(44):1439-43.

4.

American Academy of Pediatrics/American Heart Association clarification of statement on cardiovascular evaluation and monitoring of children and adolescents with heart disease receiving medications for ADHD: May 16, 2008.

American Academy of Pediatrics/American Heart Association.

J Dev Behav Pediatr. 2008 Aug;29(4):335. doi: 10.1097/DBP.0b013e31318185dc14. No abstract available.

PMID:
18698199
5.

Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.

Perrin JM, Friedman RA, Knilans TK; Black Box Working Group; Section on Cardiology and Cardiac Surgery.

Pediatrics. 2008 Aug;122(2):451-3. doi: 10.1542/peds.2008-1573. No abstract available.

PMID:
18676566
6.

Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children.

Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS.

Arch Pediatr Adolesc Med. 2007 Sep;161(9):857-64.

PMID:
17768285
7.

Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs.

Libby AM, Brent DA, Morrato EH, Orton HD, Allen R, Valuck RJ.

Am J Psychiatry. 2007 Jun;164(6):884-91.

PMID:
17541047
8.

Trends in medication treatment for ADHD.

Castle L, Aubert RE, Verbrugge RR, Khalid M, Epstein RS.

J Atten Disord. 2007 May;10(4):335-42.

PMID:
17449832
9.

Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.

Nemeroff CB, Kalali A, Keller MB, Charney DS, Lenderts SE, Cascade EF, Stephenson H, Schatzberg AF.

Arch Gen Psychiatry. 2007 Apr;64(4):466-72.

PMID:
17404123
10.

The economic impact of attention-deficit/hyperactivity disorder in children and adolescents.

Pelham WE, Foster EM, Robb JA.

Ambul Pediatr. 2007 Jan-Feb;7(1 Suppl):121-31. Review.

PMID:
17261491
11.

Should our well-child care system be redesigned? A national survey of pediatricians.

Coker T, Casalino LP, Alexander GC, Lantos J.

Pediatrics. 2006 Nov;118(5):1852-7.

PMID:
17079554
12.

Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder.

Gibson AP, Bettinger TL, Patel NC, Crismon ML.

Ann Pharmacother. 2006 Jun;40(6):1134-42. Epub 2006 May 30. Review.

PMID:
16735655
13.

Trends in the use of psychotropic medications among adolescents, 1994 to 2001.

Thomas CP, Conrad P, Casler R, Goodman E.

Psychiatr Serv. 2006 Jan;57(1):63-9.

PMID:
16399964
14.

National trends in the treatment of attention deficit hyperactivity disorder.

Olfson M, Gameroff MJ, Marcus SC, Jensen PS.

Am J Psychiatry. 2003 Jun;160(6):1071-7.

PMID:
12777264
15.

The underutilization of cardiac medications of proven benefit, 1990 to 2002.

Stafford RS, Radley DC.

J Am Coll Cardiol. 2003 Jan 1;41(1):56-61.

16.
17.

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies.

Michelson D, Adler L, Spencer T, Reimherr FW, West SA, Allen AJ, Kelsey D, Wernicke J, Dietrich A, Milton D.

Biol Psychiatry. 2003 Jan 15;53(2):112-20.

PMID:
12547466
18.

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder.

American Academy of Pediatrics. Subcommittee on Attention-Deficit/Hyperactivity Disorder and Committee on Quality Improvement.

Pediatrics. 2001 Oct;108(4):1033-44.

PMID:
11581465
19.

Long-term prognosis in attention-deficit/hyperactivity disorder.

Mannuzza S, Klein RG.

Child Adolesc Psychiatr Clin N Am. 2000 Jul;9(3):711-26. Review.

PMID:
10944664

Supplemental Content

Support Center